These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25550792)

  • 1. Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.
    Yang Z; He M; Wang K; Sun G; Tang L; Xu Z
    Int J Clin Exp Pathol; 2014; 7(11):7563-70. PubMed ID: 25550792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of RAB22A by mir-193b inhibits breast cancer growth and metastasis mediated by exosomes.
    Sun L; He M; Xu N; Xu DH; Ben-David Y; Yang ZY; Li YJ
    Int J Oncol; 2018 Dec; 53(6):2705-2714. PubMed ID: 30272274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1.
    Lenarduzzi M; Hui AB; Alajez NM; Shi W; Williams J; Yue S; O'Sullivan B; Liu FF
    PLoS One; 2013; 8(1):e53765. PubMed ID: 23335975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1.
    Hulin JA; Tommasi S; Elliot D; Hu DG; Lewis BC; Mangoni AA
    Sci Rep; 2017 Oct; 7(1):13996. PubMed ID: 29070803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive effect of metastamiR-193b and breast cancer metastasis suppressor 1 as an anti-metastatic strategy.
    Hashemi ZS; Forouzandeh Moghadam M; Khalili S; Ghavami M; Salimi F; Sadroddiny E
    Breast Cancer; 2019 Mar; 26(2):215-228. PubMed ID: 30284194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact.
    Leivonen SK; Rokka A; Ostling P; Kohonen P; Corthals GL; Kallioniemi O; Perälä M
    Mol Cell Proteomics; 2011 Jul; 10(7):M110.005322. PubMed ID: 21512034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A.
    Yin Y; Zhang B; Wang W; Fei B; Quan C; Zhang J; Song M; Bian Z; Wang Q; Ni S; Hu Y; Mao Y; Zhou L; Wang Y; Yu J; Du X; Hua D; Huang Z
    Clin Cancer Res; 2014 Dec; 20(23):6187-99. PubMed ID: 25294901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MORC4 is a novel breast cancer oncogene regulated by miR-193b-3p.
    Yang Z; Zhuang Q; Hu G; Geng S
    J Cell Biochem; 2019 Mar; 120(3):4634-4643. PubMed ID: 30320920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
    Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
    Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-211 is epigenetically regulated by DNMT1 mediated methylation and inhibits EMT of melanoma cells by targeting RAB22A.
    Yu H; Yang W
    Biochem Biophys Res Commun; 2016 Aug; 476(4):400-405. PubMed ID: 27237979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1.
    Long J; Ji Z; Jiang K; Wang Z; Meng G
    Biomed Res Int; 2015; 2015():373574. PubMed ID: 26526790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells.
    Hu H; Li S; Liu J; Ni B
    Acta Biochim Biophys Sin (Shanghai); 2012 May; 44(5):424-30. PubMed ID: 22491710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma.
    Guan G; Zhang D; Zheng Y; Wen L; Yu D; Lu Y; Zhao Y
    Int J Clin Exp Pathol; 2014; 7(9):5683-91. PubMed ID: 25337209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-193b acts as a tumor suppressor in colon cancer progression via targeting RAB22A.
    Fang Z; Li C; Li S
    Exp Ther Med; 2019 May; 17(5):3921-3928. PubMed ID: 31007734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression.
    Xiong F; Liu K; Zhang F; Sha K; Wang X; Guo X; Huang N
    Oncol Rep; 2016 May; 35(5):3000-8. PubMed ID: 26883716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.
    Deng X; Zhao Y; Wang B
    Oncol Rep; 2015 Oct; 34(4):2188-94. PubMed ID: 26238950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-224 Promotes Tumorigenesis through Downregulation of Caspase-9 in Triple-Negative Breast Cancer.
    Zhang L; Zhang X; Wang X; He M; Qiao S
    Dis Markers; 2019; 2019():7378967. PubMed ID: 30886656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.